ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test
Welcome to DNA Labs UAE, where we offer the ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test. This test helps in the diagnosis and identification of individuals who may be at an increased risk of developing atrial fibrillation type 12. Below, you will find all the important information about this test.
Test Details
The ABCC9 gene is responsible for coding a protein called ATP-binding cassette subfamily C member 9. This protein plays a crucial role in regulating ion channels in the heart. Mutations in the ABCC9 gene have been linked to various cardiac conditions, including atrial fibrillation. Atrial fibrillation type 12 specifically refers to a subtype of atrial fibrillation caused by mutations in the ABCC9 gene. While relatively rare, this subtype is associated with an increased risk of developing atrial fibrillation.
Our ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test utilizes NGS technology, also known as next-generation sequencing. This advanced genetic testing method allows for the simultaneous analysis of multiple genes or even the entire genome. By conducting this test, we can identify any mutations or variations in the ABCC9 gene that may be associated with atrial fibrillation type 12.
Components and Price
The cost of the ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test is AED 4400.0. The test requires a blood sample for analysis.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The analysis is performed using NGS technology, ensuring accurate and comprehensive results.
Test Type and Doctor
The ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a cardiologist before undergoing this test.
Test Department and Pre Test Information
This genetic test is conducted in our Genetics department. Prior to the test, it is essential to provide the clinical history of the patient who is going for the ABCC9 Gene Atrial Fibrillation Type 12 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the ABCC9 Gene Atrial Fibrillation Type 12 NGS Genetic DNA Test gene ABCC9.
Conclusion
The ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test is designed to identify individuals with mutations in the ABCC9 gene, thereby providing valuable information for diagnosis, treatment decisions, and assessing the risk of atrial fibrillation in family members. By undergoing this test, individuals can gain insights into their genetic predisposition to atrial fibrillation type 12 and take necessary precautions to maintain their heart health.
| Test Name | ABCC9 Gene Atrial fibrillation type 12 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ABCC9 Gene Atrial fibrillation type 12 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCC9 Gene Atrial fibrillation type 12 NGS Genetic DNA Test gene ABCC9 |
| Test Details |
The ABCC9 gene is a gene that codes for a protein called ATP-binding cassette subfamily C member 9. This protein is involved in the regulation of ion channels in the heart. Mutations in the ABCC9 gene have been associated with various cardiac conditions, including atrial fibrillation. Atrial fibrillation type 12 refers to a specific subtype of atrial fibrillation that is caused by mutations in the ABCC9 gene. This subtype is relatively rare and is characterized by an increased risk of developing atrial fibrillation. NGS genetic testing, also known as next-generation sequencing, is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. This type of testing can identify mutations or variations in the ABCC9 gene that may be associated with atrial fibrillation type 12. The purpose of the ABCC9 gene atrial fibrillation type 12 NGS genetic test is to identify individuals who have mutations in the ABCC9 gene and are at an increased risk of developing atrial fibrillation type 12. This information can be used for diagnostic purposes, to guide treatment decisions, and to provide information about the risk of atrial fibrillation to family members. |
